Post-Authorization Activity Table (PAAT) for Ofev

Health Canada Post-Authorization Activity Table 2019-01-24, Ofev, 100 mg, 150 mg, nintedanib, capsule, oral, Boehringer Ingelheim (Canada) Ltd.